What combination topical steroid and antibiotic eye‑drop regimen should be prescribed to treat ocular inflammation and prevent bacterial infection?

Prescription Eye Drops with Steroids and Antibiotics

For bacterial keratitis, start with antibiotic monotherapy (fluoroquinolone) alone, then add topical corticosteroids only after 2-3 days of documented clinical improvement, pathogen identification, and exclusion of fungal or Nocardia infection. 1, 2

Initial Antibiotic-Only Phase

First-Line Empiric Therapy

• Begin with topical fluoroquinolone monotherapy as the standard of care for bacterial keratitis 2
• Specific options include:
  • Moxifloxacin 0.5% (one drop three times daily for 7 days) 3
  • Levofloxacin 1.5% 2
  • Ciprofloxacin 0.3% 2
  • Ofloxacin 0.3% 2
• Single fluoroquinolone therapy demonstrates equivalent efficacy to fortified combination antibiotics 2

Critical Initial Steps

• Obtain corneal scrapings for culture before starting antibiotics to identify the pathogen 4
• For severe or central keratitis, use intensive dosing: loading dose every 5-15 minutes, then hourly applications 4
• Never use combination antibiotic-steroid drops as first-line therapy for undiagnosed bacterial keratitis, as this risks masking serious infections or worsening viral/fungal disease 5

When to Add Corticosteroids

Timing Requirements (All Must Be Met)

• Wait at least 2-3 days of progressive improvement on antibiotic therapy 1, 2
• Confirm pathogen identification from cultures 1, 5
• Rule out fungal infection completely (corticosteroids worsen fungal keratitis outcomes) 1, 5
• Rule out Nocardia infection (corticosteroids result in significantly worse visual outcomes) 1, 5
• Verify epithelial defect is healing and ulcer is consolidating 1, 5
• Ensure the infiltrate threatens or involves the visual axis/central cornea 1, 4

Evidence for Early Addition

• Adding corticosteroids within 2-3 days (rather than after 4+ days) of antibiotic therapy results in one-line better visual acuity at 3 months in non-Nocardia bacterial keratitis 1, 4
• Potential benefit exists for Pseudomonas keratitis and severe cases (ulcers covering central 4-mm pupil or vision of counting fingers or worse) 1

Specific Regimen Options

Prednisolone Acetate (Separate Drops)

• Prednisolone acetate 1% or prednisolone phosphate 1% is the studied formulation 1
• Dosing: Two drops four times daily in the affected eye 6
• Continue concomitant antibiotic therapy at full strength 6
• Use the minimum amount required to control inflammation 1

Combination Products (Tobradex or Moxifloxacin/Dexamethasone)

• Tobradex (tobramycin/dexamethasone) may be used after meeting all timing requirements above 5
• Moxifloxacin 0.5%/dexamethasone 0.1% fixed combination shows therapeutic equivalence to separate drops 7
• Fixed combinations offer simplified regimens with similar efficacy and safety 7, 8
• Critical caveat: The antibiotic component may be inadequate if the pathogen has specific resistance patterns, so only use after pathogen identification confirms susceptibility 5

Monitoring and Safety

Mandatory Follow-Up

• Examine patient within 1-2 days after initiating corticosteroid therapy 1, 5
• Monitor intraocular pressure (IOP) closely due to risk of steroid-induced glaucoma 1, 5
• Severe cases require daily follow-up initially until stable or improving 1

Long-Term Risks to Discuss

• Cataract formation with prolonged use 1
• Glaucoma development 1
• Corneal melting from inhibition of collagen synthesis 1
• Recrudescence of infection 1
• Local immunosuppression 1

Tapering Strategy

• Never taper antibiotics below 3-4 times daily to avoid subtherapeutic dosing and resistance 2
• Taper corticosteroids gradually by decreasing frequency of applications 6
• If patient was already on corticosteroids at presentation, reduce or eliminate until infection is controlled 1

Critical Pitfalls to Avoid

Absolute Contraindications for Corticosteroids

• Nocardia keratitis: Results in poor visual outcomes at 3 and 12 months 1, 5
• Fungal keratitis: Increases risk of requiring penetrating keratoplasty 1, 5
• Viral keratitis (HSV): Worsens infection and can cause corneal perforation 5
• Unidentified pathogen before cultures return 1, 5

Common Errors

• Using combination steroid-antibiotic drops as first-line without pathogen identification 5
• Adding corticosteroids before 2-3 days of documented improvement 1, 2
• Premature discontinuation of antibiotics, especially in Pseudomonas keratitis 2
• Failing to monitor IOP after starting corticosteroids 1, 5
• Discontinuing therapy prematurely if no improvement by 48 hours (should modify regimen instead) 2, 6

Special Populations at Risk

• Patients with recent fluoroquinolone use, hospitalization, advanced age, or recent ocular surgery have higher resistance risk 2
• Patients on chronic topical corticosteroids at presentation have increased risk of infectious crystalline keratopathy 1, 5

Algorithm Summary

1. Day 0: Start fluoroquinolone monotherapy after obtaining cultures 2, 4
2. Days 1-2: Monitor daily for severe cases; assess for improvement 1
3. Day 2-3: If progressive improvement documented AND pathogen identified AND fungal/Nocardia ruled out AND infiltrate threatens visual axis, add topical corticosteroid 1, 2, 5
4. Day 3+: Continue both medications with close IOP monitoring 1, 5
5. Ongoing: Taper based on clinical response, never dropping antibiotics below 3-4 times daily 2, 6